Cargando…
BCL-2 AND IAP Proteins As Potential Drug Targets
Autor principal: | Fesik, Stephen W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084163/ https://www.ncbi.nlm.nih.gov/pubmed/30147583 http://dx.doi.org/10.1100/tsw.2001.129 |
Ejemplares similares
-
Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment
por: Schwarzenbach, Christian, et al.
Publicado: (2021) -
IAP proteins as targets for drug development in oncology
por: Dubrez, Laurence, et al.
Publicado: (2013) -
Inhibitor of Apoptosis (IAP) proteins as drug targets for the treatment of cancer
por: Vaux, David L
Publicado: (2009) -
Targeting IAP proteins in combination with radiotherapy
por: Fulda, Simone
Publicado: (2015) -
Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
por: Lincoln, Frank A., et al.
Publicado: (2018)